US Corporate Board Director Changes SEC Filings — April 20, 2026

20-04-2026

On April 17, 2026, Sierra Bancorp terminated William J. Wade II as Executive Vice President & Chief Operations Officer as part of an organizational realignment, entitling him to severance equal to 12 months' salary and health insurance premiums subject to signing a release within 21 days. Christopher Treece, Executive Vice President & Chief Financial Officer since January 2020, assumed the COO role with an amended employment agreement increasing his base salary by $25,000 to $466,000 per year. Marc Wolfe, age 35 and Senior Vice President & Corporate Controller since January 1, 2026, was appointed Principal Accounting Officer.

• ·William J. Wade II's employment agreement dated July 7, 2025.
• ·Christopher Treece has served as EVP & CFO since January 2020.
• ·Marc Wolfe joined the company in September 2015; holds BBA and MBA from National University.
• ·No family relationships among directors/executive officers and Marc Wolfe; no related party transactions.
• ·Amendment to Treece's employment agreement effective April 17, 2026.
• ·Exhibit 10.1: Second amendment to Treece's employment agreement.

20-04-2026

At Travelzoo's 2026 Annual Meeting of Stockholders on April 20, 2026, shareholders elected Ralph Bartel, Christina Sindoni Ciocca, Volodymyr Cherevko, Michael Karg, and Sharry Sun to the Board of Directors, with all candidates receiving majority support ranging from approximately 94% to 97% votes for. Shareholders approved stock option grants to Global CEO Holger Bartel (600,000 shares at $5.05 per share), the General Manager U.S., and Head of Engineering, though the CEO grant saw notable opposition with 1,908,524 votes against out of roughly 6.4 million total votes. Executive compensation was also approved on an advisory basis with strong support (6,216,201 for vs. 170,683 against).

• ·HB Option granted February 19, 2026; vests semi-annually in equal 25% installments over two years, first vesting June 30, 2026; expires five years from grant date.
• ·CEO, General Manager U.S., and Head of Engineering stock option proposals approved by stockholders on April 20, 2026.
• ·Annual meeting held via webcast at www.virtualshareholdermeeting.com/TZOO2026.
• ·Volodymyr Cherevko, Michael Karg, and Sharry Sun designated as independent directors per NASDAQ standards.

20-04-2026

enCore Energy Corp. appointed Richard H. Little as Chief Executive Officer and Director, replacing Robert Willette effective immediately, while founder William M. Sheriff returned as Executive Chair. The Board outlined a renewal program emphasizing cost management, permitting acceleration, and asset development amid acknowledged challenges like permitting delays and operational inefficiencies. A corporate update conference call is scheduled for April 23, 2026, at 11 AM ET.

• ·Conference call details: Thursday, April 23, 2026 at 11 AM ET via https://app.webinar.net/OlMrE49n2DW
• ·Renewal commitments: enhanced shareholder communications, cost management and efficiency, timely permitting, aggressive asset development, accretive M&A

20-04-2026

OpenText Corporation announced on April 20, 2026, that James McGourlay transitions from Interim CEO to President, Chief Client Officer, reporting to new CEO Ayman Antoun, to focus on client experience, professional services, renewals, and cloud migration. Simultaneously, Paul Duggan is stepping down from President, Chief Customer Officer to Executive Vice President, Special Advisor, with his full departure from the company on July 1, 2026. This leadership transition aims to reinforce client outcomes and growth in core products and enterprise AI data management.

• ·James McGourlay previously served as Interim CEO and held senior roles in sales, customer operations, and executive management.
• ·Paul Duggan will remain on the Executive Leadership Team until July 1, 2026.
• ·OpenText trades on NASDAQ: OTEX and TSX: OTEX.

20-04-2026

Neurogene Inc. (Nasdaq: NGNE) announced the appointment of Christy Shafer as Chief Commercial Officer to lead commercial strategy and launch readiness for NGN-401 gene therapy for Rett syndrome, and Christine Mikail, J.D., its President and CFO, to the Board of Directors. Ms. Shafer brings over 20 years of experience in building commercial organizations and launching therapies for rare neurological diseases, including roles at Avidity Biosciences, Marinus Pharmaceuticals, and Alexion. These additions enhance Neurogene's executive team and board expertise in commercialization and strategic transactions as it advances NGN-401 toward potential approval.

• ·Filing date: April 20, 2026
• ·Neurogene's Annual Report on Form 10-K for year ended December 31, 2025, filed March 17, 2026

20-04-2026

WW International, Inc. (Nasdaq: WW) appointed Heather Thiltgen, President of Presbyterian Health Plan, to its Board of Directors effective April 20, 2026, expanding the board to six independent members. Ms. Thiltgen brings extensive healthcare expertise in GLP-1 therapies, regulatory navigation, profitable growth, and member outcomes, aligning with the company's integrated weight health strategy. Chairman Gene Davis and Nominating Committee Chair Nikolaj Sjoqvist highlighted her value in executing long-term strategy amid recent director additions like Sue Gove and Lisa Gavales.

• ·Ms. Thiltgen will serve until the Company’s 2026 annual meeting of shareholders and is a member of the Board’s Compensation and Benefits Committee.
• ·Appointment announced via Exhibit 99.1 press release on April 20, 2026.

20-04-2026

Fermi Inc. announced 'Fermi 2.0' strategic evolution, including leadership transitions with Marius Haas appointed Chairman, Toby Neugebauer departing as CEO but remaining on the Board, Miles Everson resigning as CFO to become a Board Director, and Jeffrey S. Stein elected to the Board. To ensure continuity, an Office of the CEO was created with Co-Presidents Jacobo Ortiz Blanes and Anna Bofa, alongside a search for a new CEO via Heidrick & Struggles and negotiations for an Interim CFO. The company is establishing new headquarters in Dallas and an office in Amarillo, reaffirming commitment to Project Matador and Texas Tech University System partnership amid its shift from startup to scaled enterprise.

• ·Fermi co-founded by former U.S. Energy Secretary Rick Perry and Toby Neugebauer.
• ·Leadership Search Committee includes Haas, McIntire, and Robbin-Coker.
• ·New offices: Dallas headquarters and Amarillo presence at Project Matador site.

20-04-2026

Veeva Systems Inc. announced on April 20, 2026, that Josh Faddis intends to retire from his role as Senior Vice President, General Counsel, effective November 1, 2026, and transition into a part-time advisor position. The company plans to appoint a successor upon his transition. No further details on the successor or any financial impacts were disclosed.

20-04-2026

Super Micro Computer, Inc. held its Annual Meeting on April 15, 2026, where stockholders elected Charles Liang, Tally Liu, and Sherman Tuan as Class I directors to serve until the 2028 annual meeting. Stockholders also approved an advisory resolution on named executive officer compensation, ratified BDO USA, P.C. as the independent auditor for fiscal year ending June 30, 2026, and approved the further amendment and restatement of the 2020 Equity and Incentive Compensation Plan, increasing authorized shares by 15,000,000 to a total of 118,000,000 shares available for awards. All four proposals passed with majority support.

• ·Proposal 2 (Say-on-Pay): 259,720,162 Votes For, 19,769,911 Against, 811,482 Abstentions
• ·Proposal 3 (Auditor Ratification): 426,001,144 Votes For, 4,552,685 Against, 1,080,929 Abstentions
• ·Proposal 4 (Equity Plan): 227,820,618 Votes For, 51,703,394 Against, 777,543 Abstentions
• ·No grants under the Plan after April 15, 2036
• ·Plan authorizes awards to non-employee directors, officers, employees, consultants

20-04-2026

On April 14, 2026, Asana, Inc. directors Matt Cohler (Class I), Adam D’Angelo (Class III), and Lorrie Norrington (Lead Independent Director, Class II) tendered resignations effective at the June 8, 2026 Annual Meeting as part of an orderly board refreshment process, reducing the board size from 10 to 7 members. There were no disagreements with the company on operations, policies, or accounting. The board appointed Krista Anderson-Copperman as the new Lead Independent Director effective post-meeting.

• ·Lorrie Norrington served on the Board since July 2019 and as Lead Independent Director since August 2021.
• ·Adam D’Angelo served on the Board since December 2008.
• ·Matt Cohler served on the Board since November 2009.
• ·Departures not due to any disagreements on operations, policies, practices, or accounting.

20-04-2026

On April 16, 2026, Steven C. Gilman, a member of the Board of Directors of SCYNEXIS, Inc., notified the company of his intent to retire and not stand for reelection at the 2026 annual meeting of stockholders. Dr. Gilman's term as director and his roles as Chair of the Compensation Committee and member of the Nominating and Corporate Governance Committee will end at the conclusion of the 2026 Annual Meeting. The retirement is not due to any disagreement with the company's operations, policies, practices, strategy, management, or Board.

• ·The Form 8-K was filed on April 20, 2026.
• ·SCYNEXIS, Inc. common stock (SCYX, par value $0.001 per share) trades on The Nasdaq Capital Market.

20-04-2026

On April 17, 2026, Dr. Jordan R. Asher, a member of the Board of Directors of Brookdale Senior Living Inc., notified the company that he will not stand for re-election at the 2026 annual meeting of stockholders. Dr. Asher will continue serving until the expiration of his term at the 2026 Annual Meeting. His decision is not due to any disagreement with the company, the Board, or management on operations, policies, or practices.

• ·Filing signed by Chad C. White on April 20, 2026

20-04-2026

Enpro Inc. announced on April 20, 2026, that Larisa R. Joiner mutually agreed to step down as Senior Vice President and Chief Information Officer effective April 23, 2026, amid a search for her replacement. Ms. Joiner will remain an employee at her current salary and benefits until July 31, 2026, to facilitate a smooth transition and will be eligible for severance benefits under the Senior Officer Severance Plan.

• ·Severance benefits described in definitive proxy statement filed March 23, 2026, on page 37 ('Severance policy') and page 49 ('Severance benefits').
• ·Report signed by Robert S. McLean on April 20, 2026.

20-04-2026

On April 20, 2026, Westrock Coffee Company's Board appointed A. Wellford Tabor as a director, effective immediately, to fill the vacancy created by R. Brad Martin's retirement, and also appointed him to the Audit & Finance Committee. The Board reduced its size by one to account for Josie Natori's prior retirement. Mr. Tabor, designated by the RVAC Majority under the Investor Rights Agreement, is Head of Direct Investments and Managing Director at HF Capital, LLC.

• ·Mr. Tabor will serve until the 2027 annual stockholder meeting.
• ·HF Direct Investments Pool, LLC is a greater than 10% holder of the Company's common stock.
• ·Company entered into an indemnification agreement with Mr. Tabor.
• ·No arrangements or understandings other than Investor Rights Agreement for Mr. Tabor's selection.
• ·No Item 404(a) disclosable transactions between Mr. Tabor and the Company except as noted.

20-04-2026

Celanese Corporation elected Anne P. Noonan to its Board of Directors effective April 20, 2026, bringing the total to 10 members, nine of whom are independent. Ms. Noonan, with over 30 years of leadership in chemicals and materials including CEO roles at Summit Materials and OMNOVA Solutions, will stand for re-election at the 2027 Annual Meeting. Celanese, a Fortune 500 company, employs more than 11,000 worldwide and reported 2025 net sales of $9.5 billion.

• ·Ms. Noonan, age 62, holds BS Honors in chemistry and MS in organometallic chemistry from University College Dublin.
• ·Previous roles: President and CEO of Summit Materials (Sep 2020-Feb 2025), President and CEO of OMNOVA (2016-2020), and 27 years at Chemtura.

20-04-2026

On April 14, 2026, Revium Rx. appointed Amir Avraham as permanent Chief Executive Officer effective February 1, 2026, following his interim role since May 22, 2025, with a monthly salary of NIS 55,000, a potential $50,000 bonus upon securing $5 million in new equity investments within 18 months, and options for 1,300,000 shares plus up to 600,000 more tied to milestones. The Board also appointed Shlomi Schwartzblat as Director and Chairman effective immediately. No performance declines or flat metrics reported.

• ·CEO employment includes 12-month non-competition and non-solicitation covenants.
• ·Remote work and Remote Control Management permitted subject to Company approval and operational efficiency.
• ·Mr. Schwartzblat's term as Director expires at 2026 annual stockholder meeting; no related party transactions.

20-04-2026

Magnite announced the retirement of CFO David Day, who will continue in the role through September 30, 2026, and then serve as a special advisor until May 31, 2027, while the Board initiates a search for a successor involving both internal and external candidates. The company reaffirms its previously disclosed expectations for Q1 and full year 2026 from the Q4 2025 earnings release. Day's tenure included key roles in the 2020 Rubicon Project-Telaria merger and acquisitions of SpotX and SpringServe.

• ·David Day's prior executive roles at high-growth technology companies including Overture Services, Yahoo! Search Marketing, Spot Runner, and ReachLocal.
• ·David Day began career in public accounting with Arthur Andersen and PricewaterhouseCoopers, including overseas assignment in Frankfurt, Germany.
• ·Q4 2025 earnings release issued on February 25, 2026.

20-04-2026

Synopsys held its 2026 Annual Meeting on April 16, 2026, where stockholders elected all ten director nominees with strong support (For votes ranging from 133,355,694 to 145,900,556). Stockholders approved the Amended and Restated Equity Incentive Plan (143,264,153 For vs 4,027,288 Against), advisory approval of named executive officer compensation (134,772,793 For), and ratified KPMG LLP as independent auditors (150,960,889 For); however, they rejected a stockholder proposal on the right to act by written consent (59,013,869 For vs 88,134,590 Against). A total of 163,586,092 shares were present, representing a quorum out of 191,561,935 outstanding shares.

• ·Proxy statement filed February 19, 2026
• ·Equity Incentive Plan filed as Exhibit 10.1

20-04-2026

Ceva, Inc. announced the retirement of long-serving Board Member Sven-Christer Nilsson, who will not seek re-election at the annual stockholder meeting on June 2, 2026, after serving since November 2002. Nilsson served on the Audit Committee, Strategy Committee, and as Chair of the Nomination and Governance Committee. Chairman Peter McManamon thanked Nilsson for over 20 years of dedicated service, leadership, and telecommunications expertise from roles at Ericsson.

• ·Ceva provides IP for connectivity (5G, cellular IoT, Bluetooth, Wi-Fi, UWB) and Edge AI technologies.
• ·Contact for more information: Yaniv Arieli (+972.9.961.3770, yaniv.arieli@ceva-ip.com); Richard Kingston (+1.650.220.1948, richard.kingston@ceva-ip.com).

20-04-2026

Howard Widra notified the Board on April 14, 2026, of his resignation as trustee and Chairman of MidCap Apollo Institutional Private Lending, effective June 18, 2026, due to his retirement from Apollo Global Management, Inc., with no disagreements noted. The Board appointed Tanner Powell as trustee and Chairman, effective the same date, who has served as the Company's CEO since March 2024. This leadership transition ensures continuity with an internal Apollo executive.

• ·Mr. Powell joined Apollo in 2006 and has served as CEO of MidCap Financial Investment Corporation since August 2022.
• ·Mr. Powell served as President of MidCap Financial Investment Corporation from May 2018 to August 2022 and Chief Investment Officer for its investment adviser from June 2016 to August 2022.
• ·No arrangement or understanding with any other person for Mr. Powell's appointment; no reportable transactions under Item 404(a) of Regulation S-K.

20-04-2026

On April 14, 2026, Howard Widra notified the Board of MidCap Financial Investment Corporation of his resignation as Director and Executive Chairman, effective at the close of business on June 18, 2026, due to his previously announced retirement from Apollo Global Management, Inc. Mr. Widra will not stand for re-election at the Company's 2026 annual meeting of stockholders. The resignation is explicitly stated to not result from any disagreement with the Company, its investment adviser, the Board, or their affiliates regarding operations, policies, or practices.

• ·Securities registered: Common Stock ($0.001 par value, MFIC on NASDAQ Global Select Market); 8.00% Notes due 2028 (MFICL on NASDAQ Global Select Market)
• ·Filing signed on April 20, 2026

20-04-2026

National Research Corporation filed a Certificate of Amendment to its Certificate of Incorporation, changing its name to NRC Health. The amendment, adopted under Delaware General Corporation Law Section 242, confirms total assets are not less than $10,000,000 and was signed by CFO Shane Harrison on April 15, 2026. No other changes to the Certificate of Incorporation were made.

• ·Original Certificate of Incorporation filed June 30, 2021
• ·Amendment amends Article I only
• ·Waiver requested for corporate name identifying words under Delaware Section 102(a)(1)(i)

20-04-2026

Westlake Chemical Partners LP announced the appointment of Jonathan H. Baksht as Senior Vice President and Chief Financial Officer and director of the General Partner, effective June 15, 2026, succeeding M. Steven Bender, who will retire by year-end and transition to Special Advisor. Baksht brings extensive experience from roles at Fortune Brands Innovations, Pactiv Evergreen Inc., and Valaris Limited. CEO Jean-Marc Gilson expressed confidence in Baksht's contributions to the Partnership's growth, while thanking Bender for his service since inception.

• ·Baksht's prior roles: Executive VP and CFO at Fortune Brands Innovations (May 2025-Mar 2026), CFO at Pactiv Evergreen (May 2022-May 2025), CFO at Valaris Limited (Nov 2015-Sep 2021)
• ·Baksht's education: BS Electrical Engineering (University of Texas at Austin), MBA (Kellogg School of Management, Northwestern University)
• ·Bender's transition effective June 15, 2026; full retirement by end of 2026
• ·Headquartered in Houston; website: http://www.wlkpartners.com/
• ·Contact numbers: Ben Ederington and Steve Bender at 713-960-2900

20-04-2026

Snap Inc. announced that Chief Financial Officer Derek Andersen notified the company on April 17, 2026, of his departure for a new opportunity, with his last day expected to be May 8, 2026; the departure is not due to any disagreements on accounting, strategy, or operations. In connection, the company plans to appoint current Vice President of Finance, Strategy, and Corporate Development Doug Hott as the new CFO. Compensation details for Mr. Hott have not been determined and will be disclosed via amendment if necessary.

• ·Doug Hott has served as VP of Finance, Strategy and Corporate Development since July 2024, and previously as VP of Finance from August 2019 to July 2024.
• ·Doug Hott holds a B.S. in Physics from Bradley University, M.S. in Astrophysics, and M.B.A. from University of Cincinnati.
• ·No family relationships or material related transactions involving Doug Hott with board or executives.

20-04-2026

Westlake Corporation (NYSE: WLK) announced the appointment of Jonathan H. Baksht as Senior Vice President and Chief Financial Officer, reporting to President and CEO Jean-Marc Gilson. Baksht succeeds M. Steven Bender, who will transition to Special Advisor effective June 15, 2026, and retire by year-end after 21 years of service. The company highlighted Baksht's extensive experience in oil and gas, packaging, and building products from prior CFO roles at Fortune Brands Innovations, Pactiv Evergreen, and Valaris Limited.

• ·Announcement date: April 20, 2026
• ·Baksht's prior roles: CFO at Fortune Brands Innovations (May 2025 - March 2026), CFO at Pactiv Evergreen (May 2022 - May 2025), various positions at Valaris (2013-2021 including CFO from Nov 2015)
• ·Baksht's board roles: Director at Duxion Motors Inc. (since Jan 2022), previously ARO Drilling (Apr 2019 - Sep 2021)
• ·Baksht's education: BS Electrical Engineering (University of Texas at Austin), MBA (Kellogg School of Management, Northwestern University)
• ·Contact: Investor Inquiries - Steve Bender, 713-960-9111

20-04-2026

On April 20, 2026, Martin J. Joyce, a member of the Board of Directors of Aldeyra Therapeutics, Inc., notified the company of his decision not to stand for re-election at the upcoming 2026 annual meeting of stockholders. Mr. Joyce will continue serving on the Board until his term expires at the 2026 Annual Meeting. The decision was not due to any disagreement with Aldeyra.

20-04-2026

Blue Ridge Bankshares, Inc. approved compensation adjustments for Harry Golliday, its Interim Chief Executive Officer and Interim President, and Interim CEO of Blue Ridge Bank, N.A., increasing his annual base salary to $525,000 and short-term incentive opportunity to up to 50% of base salary. These changes follow his previously announced appointment and do not amend his May 3, 2024 employment agreement with the Bank.

• ·Event date: April 15, 2026
• ·Filing date: April 20, 2026
• ·Employment agreement dated May 3, 2024, remains in place

20-04-2026

Alpha Cognition Inc. (ACOG) appointed Bethany Sensenig as a director on April 15, 2026. Ms. Sensenig has extensive finance and operations experience, including CFO roles at Radius Health, 9 Meters Biopharma, and Minovia Therapeutics, and VP at Biogen managing over $1B in annual revenue across 30 countries. In connection with her appointment, she received 5,489 restricted stock units and 6,991 stock options with an exercise price of $6.65 per share, both vesting one year from grant.

• ·Ms. Sensenig serves on the boards of Supernus Pharmaceuticals (SUPN) and KalVista Pharmaceuticals (KALV).
• ·Compensation in accordance with the Company’s non-employee director policy.
• ·No family relationships with directors/officers or material interests requiring disclosure under Item 404(a) of Regulation S-K.

20-04-2026

Kingstone Companies, Inc. extended the employment agreement of President and CEO Meryl Golden through January 10, 2029, previously set to expire on January 10, 2027, following a recommendation from the Compensation Committee. The Board expressed confidence in Ms. Golden's leadership, citing record profitability, a roadmap for measured expansion including entry into California, and her goal of achieving $500 million in direct written premium by 2029. Chairman Thomas Newgarden highlighted her role in executing the growth plan to benefit shareholders.

• ·Kingstone Insurance Company (KICO) licensed in New York, New Jersey, Rhode Island, Massachusetts, Connecticut, Pennsylvania, New Hampshire, and Maine.
• ·Additional details on employment agreement terms to be included in a forthcoming Current Report on Form 8-K.

20-04-2026

Astec Industries, Inc. (NASDAQ: ASTE) announced on April 20, 2026, that Chad Hartley will join as Group President – Infrastructure Solutions and member of the Executive Leadership Team effective May 11, 2026. Hartley brings experience from Regal Rexnord where he was most recently President, Conveyance Solutions, and prior roles at Emerson Electric in operations, supply chain, sales, marketing, and general management. CEO Jaco van der Merwe highlighted Hartley's strong track record in multinational manufacturing operations.

• ·Astec's segments: Infrastructure Solutions (road building, asphalt and concrete plants, thermal and storage solutions) and Materials Solutions (aggregate processing equipment)
• ·Hartley's prior expatriate assignment: Vice President & General Manager in Shanghai, China

20-04-2026

On April 16, 2026, VisionWave Holdings, Inc. appointed Shayna Quinn, age 33, as an independent director to its Board, effective immediately, until the next annual stockholder meeting. Ms. Quinn brings over nine years of experience in technology and transportation sectors, including roles at Windels Marx, Kaptyn, and Juno where she managed operations for 48,000 independent contractors. Compensation includes an annual cash retainer of $36,000 and $60,000 in restricted stock vesting after 12 months.

• ·Ms. Quinn determined to be independent under Nasdaq Listing Rule 5605(a)(2) and SEC rules.
• ·No arrangements or understandings for her selection; no related transactions under Item 404(a) of Regulation S-K.
• ·Director Agreement consistent with Company's Director Compensation Policy; expense reimbursement per company policy.

20-04-2026

Bristow Group Inc. (NYSE: VTOL) announced the planned retirement of Alan Corbett, Chief Operating Officer, Government Services, at the end of 2026, with him remaining in his role through the appointment of a successor and supporting the transition. Under Corbett's leadership since February 2023, the company secured major long-term contracts including the UK Search and Rescue Second-Generation program, Irish Coast Guard contract, and Netherlands and Dutch Caribbean Coast Guard programs. The company has initiated a global search for a replacement with an executive search firm.

• ·Corbett joined Bristow in 2014 and held prior roles including Region Director of the Europe Business Unit, Region Director of the Europe Caspian Region, Vice President of EAMEA, and Senior Vice President for Europe, Africa, Middle East, Asia, and Search and Rescue.
• ·Bristow provides aviation services to customers in Australia, Brazil, Canada, Chile, the Dutch Caribbean, the Falkland Islands, Ireland, the Netherlands, Nigeria, Norway, Spain, Suriname, Trinidad and Tobago, the United Kingdom, and the United States.

20-04-2026

Massimo Group (NASDAQ: MAMO) announced the appointment of Quenton Petersen as Chief Executive Officer, effective April 14, 2026, with David Shan transitioning to Executive Chairman while remaining involved in strategic direction and operations. Petersen, who has been with the company for over nine years, highlighted the company's strengths in utility vehicles and electric mobility, and plans to explore AI-enabled features and expansions into facility operations and smart mobility. David Shan expressed full confidence in Petersen's leadership for continued success.

• ·Announcement made on April 20, 2026 from Garland, TX.
• ·Massimo Group serves agricultural, commercial, and recreational customers through a nationwide distribution network.
• ·Company focused on scalable platforms across mobility, equipment, and emerging intelligent automation applications.

20-04-2026

Purebase Corporation (PUBC) announced on April 17, 2026, the termination of Stephen Gillings' employment as Chief Financial Officer. The 8-K filing was made on April 20, 2026, and signed by CEO A. Scott Dockter. No details on the reason for termination or any successor were provided.

• ·Company address: 14110 Ridge Road, Sutter Creek, California 95685
• ·Company phone: (209) 991-2180
• ·No securities registered pursuant to Section 12(b) of the Act

20-04-2026

1-800-FLOWERS.COM, Inc. announced the final separation of Thomas Hartnett, who transitioned from President to Special Advisor on November 3, 2025, and departed the company on February 28, 2026. Effective April 17, 2026, the company entered into separation arrangements with Mr. Hartnett, including $823,846 in continued base salary payments over 68 weeks, pro rata FY2026 bonus eligibility if performance targets are met, healthcare continuation, accelerated vesting of restricted stock grants from December 2023 and November 2024, and extended exercise period for November 2022 stock options. The arrangements also include a general release of claims and compliance with restrictive covenants.

• ·Transition to Special Advisor: November 3, 2025
• ·Full departure from company: February 28, 2026
• ·Separation arrangements effective: April 17, 2026
• ·Restricted stock grants accelerated: December 2023 and November 2024
• ·Stock options exercise extension: November 2022 grants